Wird geladen...

A new model for end-stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt

BACKGROUND & AIMS: Cirrhotics undergoing transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites or recurrent variceal bleeding are at risk for decompensation and death. This study examined whether a new model for end-stage liver disease (MELDNa), which incorporates serum sod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Guy, Jennifer, Somsouk, Ma, Shiboski, Stephen, Kerlan, Robert, Inadomi, John M., Biggins, Scott W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2009
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2783337/
https://ncbi.nlm.nih.gov/pubmed/19560557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2009.06.009
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!